Edwards Lifesciences Corporation (EW:NYSE) closed at $93.26 on November 2, 2026, up 1.36% on the day. The stock trades 3.1% below its 52-week high of $96.29 and 24.9% above its 52-week low of $74.66. Over the past year, it gained 12.3%. Edwards Lifesciences Corporation is part of the Health Care sector (Industrial Specialties).
In 252 trading sessions since October 31, 2025, EW closed higher on 129 days (51%). Its best day was April 24, 2026 (+5.56%) and its worst was February 12, 2026 (-3.64%). It never moved 10% or more in a single session.
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and their delivery systems for the nonsurgical replacement of heart valves. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral replacement, and minimally invasive aortic heart valve system; and tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve. In addition, it produces pericardial valves from biologically inert animal tissue; and provides heart valve repair therapies, including annuloplasty rings and systems. Further, the company offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; pulmonary artery catheters; and Oximetry Central Venous Catheters for continuous measurement of central venous oxygen saturation. Additionally, its critical care products include disposable pressure monitoring devices and closed blood samplin...
Find more stocks like EW with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.